Summary:
A Phase III open label study on how the body absorbs, distributes, breaks down and eliminates the investigational drug after multiple applications.
Qualified Participants Must:
• Be between 18 and 74 years of age
•
Have a low testosterone blood level to be in the study
•
Be willing to complete two days of labs, one at the beginning of the study and one at the end
Qualified Participants May Receive:
Study drug for 3 months and a stipend for their time and travel.